Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.
Follow-Up Questions
What is the price performance of LXGTF stock?
The current price of LXGTF is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Lexington Biosciences Holdings Corp?
Lexington Biosciences Holdings Corp belongs to N/A industry and the sector is N/A
What is Lexington Biosciences Holdings Corp market cap?
Lexington Biosciences Holdings Corp's current market cap is $378.684
